World's Best Scientists 2026 revealed!

Bita Esmaeli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bita Esmaeli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Bita Esmaeli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bita Esmaeli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Bita Esmaeli is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple areas within medicine, particularly focusing on oncology, surgery, ophthalmology, epidemiology, and dermatology. Their scholarly work involves a detailed exploration of ocular oncology and treatments, nonmelanoma skin cancer studies, ear and head tumors, salivary gland tumors diagnosis and treatment, cancer and skin lesions, oral and maxillofacial pathology, and cancer immunotherapy and biomarkers.

Esmaeli's recent publications reflect ongoing contributions to clinical and translational research in cancer and ophthalmic oncology. Selected recent papers include:

  • Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, 2021, Clinical Cancer Research
  • Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options, 2021, Progress in Retinal and Eye Research
  • Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy, 2020, Journal for ImmunoTherapy of Cancer
  • Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma, 2020, Ophthalmic Plastic and Reconstructive Surgery
  • The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit, 2023, Ocular Oncology and Pathology

The scientist collaborates frequently with several colleagues, including Renata Ferrarotto, J. Matthew Debnam, Jing Ning, Priyadharsini Nagarajan, and Steven J. Frank. Their work often appears in specialized publication venues with multiple contributions in:

  • Ophthalmic Plastic and Reconstructive Surgery
  • British Journal of Ophthalmology
  • Journal of Clinical Oncology
  • Investigative Ophthalmology & Visual Science
  • Clinical Cancer Research

Their research areas branch into various subfields of medicine with a strong emphasis on the treatment and diagnosis of cancers affecting the eye and surrounding tissues. Esmaeli's work engages deeply with oncology, emphasizing surgery and the epidemiology of ocular malignancies. This multidisciplinary focus informs advances in understanding tumors of the eye and head and neck region, including targeted immunotherapy approaches.

Esmaeli's body of work contributes particularly to developing therapeutic options for rare and complex cancers such as conjunctival and uveal melanoma as well as cutaneous squamous cell carcinoma. By addressing molecular profiles and immune responses, their research plays a role in advancing immunotherapy and eye-preserving treatments.

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

    Nuhad K. Ibrahim;Neil Desai;Sewa Legha;Patrick Soon-Shiong

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

    A. Gordon Robertson;Juliann Shih;Juliann Shih;Christina Yau;Ewan A. Gibb

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer

    Francisco J. Esteva;Vicente Valero;Daniel Booser;Laura T. Guerra

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Uveal Melanoma: From Diagnosis to Treatment and the Science in Between

    Chandrani Chattopadhyay;Dae Won Kim;Dan S. Gombos;Junna Oba

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • Metastatic tumors of the orbit and ocular adnexa.

    S Mehdi Ahmad;Bita Esmaeli

  • Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α

    Fadi Braiteh;Cynthia Boxrud;Cynthia Boxrud;Cynthia Boxrud;Bita Esmaeli;Razelle Kurzrock;Razelle Kurzrock;Razelle Kurzrock

  • Visual Outcome and Ocular Survival after Penetrating Trauma: A Clinicopathologic Study

    Bita Esmaeli;S. G. Elner;M. A. Schork;V. M. Elner

  • Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

    Hua-Sheng Chiu;Sonal Somvanshi;Ektaben Patel;Ting-Wen Chen

  • Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma

    Misha Faustina;Roxana Diba;M.Amir Ahmadi;Brett F. Gutstein

  • Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner

    Jahan S. Khalili;Xiaoxing Yu;Ji Wang;Brendan C. Hayes

  • Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.

    Bita Esmaeli;Amir A. Ahmadi;Adel Youssef;Roxana Diba

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma (vol 32, pg 204, 2017)

    A.G. Robertson;J.L. Shih;C. Yau;E.A. Gibb

Frequent Co-Authors

Victor G. Prieto
Victor G. Prieto The University of Texas MD Anderson Cancer Center
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
William H. Morrison
William H. Morrison The University of Texas MD Anderson Cancer Center
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Andrew D. Cherniack
Andrew D. Cherniack Broad Institute
Jeffrey N. Myers
Jeffrey N. Myers The University of Texas MD Anderson Cancer Center
Christina Yau
Christina Yau University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA offers a variety of alternative career pathways through online degrees. Many students consider nursing as a practical and rewarding choice, with flexible programs that can fit different schedules and backgrounds.

For those interested in affordability, it's common to research how much is online nursing school before committing to a program. Comparing tuition costs and financial aid options can make a significant difference in long-term student debt.

Advancing further, nurses can pursue a phd in nursing online, gaining advanced research skills and enhancing their career prospects. Meanwhile, licensed RNs looking to boost their qualifications may benefit from finding the cheapest rn to bsn online programs.

Even those without a nursing background can get started via msn direct entry programs online. These programs are designed to fast-track entry into advanced nursing roles for non-nursing degree holders. Together, these options open up diverse routes within healthcare and make the field more accessible than ever.

Best Scientists Citing Bita Esmaeli

Trending Scientists

Recently Published Articles